A Study to Assess the Relative Bioavailability of Oral Tavapadon in Healthy Adult Participants

Clinical trial NCT06895356 · COMPLETED

Trial details

NCT number: NCT06895356
Sponsor: AbbVie
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2025-03-26
Primary completion: 2025-06-16
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.